Pharmaceuticals
10 pharmaceutical forecasting experts
These ten professionals have led commercial forecasting for drugs in their own roles at pharmaceutical and biotech companies. A reader can learn how forecasting teams inside drug companies build their forecasts and support commercial decisions.
Professionals to explore
01—10Andre Sanchez
LinkedInExperience: Director - Commercial Forecasting in Cardiovascular · Amgen
Director - Commercial Forecasting in Cardiovascular at Amgen since 2025, where the profile says this person leads the commercial forecasting team for the cardiovascular business unit. Former Associate Director - Commercial Forecasting & Analytics in Obesity (2024–2025) and Senior Manager - Commercial Forecasting in Inflammation (2021–2023) at Amgen.
Ben Zimmerman
LinkedInExperience: Head of Global Forecasting and Business Analytics · Genmab
Head of Global Forecasting and Business Analytics at Genmab since 2024, a role the profile describes as global forecasting and analytics across the entire portfolio in oncology, hematology, immunology and inflammation. Former Oncology Strategic Planning & Forecasting Director at Bristol Myers Squibb (2020–2021) and Oncology Strategic Planning & Forecasting Associate Director there (2016–2020).
Brian Binns
LinkedInExperience: Director, US Forecasting - Rare Disease · AstraZeneca
Former Director, US Forecasting - Rare Disease at AstraZeneca (2024–2026) and Director, US Forecasting - HIV PrEP at Gilead Sciences since 2026. The profile also lists Director, Forecasting and Business Analytics - Rare Disease at Mirum Pharmaceuticals, Inc. (2022–2023) and says this person orchestrates global forecasting models and strategies and delivers insights to commercial leadership.
Cyril Thomson
LinkedInExperience: Sr. Director and Head of Global Commercial Forecasting and Portfolio Analytics · CSL
Sr. Director and Head of Global Commercial Forecasting and Portfolio Analytics at CSL since 2024 and former Director, Global Commercial Forecasting and Decision Analytics at CSL (2020–2024). The profile says this person leads a global commercial forecasting and portfolio analytics function for a specialty biopharmaceutical focused on rare diseases, including long range forecasting and decision analytics for a portfolio of 30+ assets.
Jeffrey Seguritan
LinkedInExperience: Director, US General Medicines Forecasting · Sanofi
Former Director, US General Medicines Forecasting at Sanofi (2019–2023), where the profile says this person led forecast planning and development for the US General Medicines portfolio covering 100+ SKUs and managed a team of forecasting professionals. The profile also lists Director, General Medicines Forecasting at Sanofi (2018–2019) and Director, CardioMetabolic Strategic Analytics there since 2023.
Jonas Sibomana
LinkedInExperience: Senior Director, Forecasting and Performance Reporting · Sage Therapeutics
Senior Director, Forecasting and Performance Reporting at Sage Therapeutics since 2022. Former Forecasting Director, US Respiratory Biologics at AstraZeneca (2019–2021), Insights Forecasting Leader Respiratory inhaled at AstraZeneca (2016–2019) and Director, Global Respiratory Biologics Insights & Analytics there (2021–2022).
Michael Bragin
LinkedInExperience: Director BD&L Forecasting and Analytics · CSL
Director BD&L Forecasting and Analytics at CSL since 2025, a role the profile says drives decision-making across commercial assessment and BD&L due diligence through commercial revenue forecasting and product and pipeline portfolio analytics. Former Director, North American Forecasting & Analytics at Kyowa Kirin, Inc.- U.S. (2023–2024) and Director, Forecasting & Commercial Analytics at Karyopharm Therapeutics Inc. (2022–2023).
Nicole Anderson
LinkedInExperience: Executive Director, US Forecasting · Amgen
Executive Director, US Forecasting at Amgen since 2026 and former Director Rare Disease Forecasting at Amgen (2024–2026). The profile also lists Business Development Forecasting & Analytics at Amgen (2022–2024) and Sr. Mgr Pipeline & BD Forecasting at Lundbeck (2021–2022).
Parth Parikh
LinkedInExperience: Director, Forecasting · Teva Pharmaceuticals
Director, Forecasting at Teva Pharmaceuticals since 2024, in the Innovative Medicines business according to the profile. Former Director, Global Forecasting at BioCryst Pharmaceuticals, Inc. (2023–2024), Director, Forecasting (Malignant & Non-malignant Hematology) at Novartis (2021–2023) and Associate Director, Forecasting at Helsinn Group (2018–2019).
Puneet Swami
LinkedInExperience: Head of Oncology Forecasting & Insights- US and Global · Merck
Former Head of Oncology Forecasting & Insights- US and Global at Merck (2023–2025) and Executive Director Strategic Forecasting Merck at Merck since 2026. The profile also lists Head of Solid Tumors Forecasting US & Global (2023) and Director Global Oncology Forecasting & Analytics (2021–2023) at Takeda Oncology.
Choose the right perspective
Match the person's forecasting scope to your question, since forecasting one brand in one country differs from building global portfolio or business development forecasts. Also consider the therapy area and product stage you care about, and ask how directly the person built the models versus led a team that did.
Questions to take into the conversation
- 01How do you build a forecast for a drug that has not launched yet, and which assumptions move the number most?
- 02How do you reconcile a forecast with what commercial and finance leaders want to see, and how do you handle pushback?
- 03What do you track after launch to tell whether the forecast was wrong or the execution was?
Reaching pharmaceutical forecasting experts
How can I contact one of these pharmaceutical forecasting experts?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 8 companies, including Amgen, Genmab and AstraZeneca, based on profile data retrieved on October 4, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach pharmaceutical forecasting experts?
You choose the offer, starting at $5 per person. It includes Instant Expert's 20% fee, so an offer that pays the person $100 costs you $125. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot and may describe past or present roles. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal